Treatment discordance in the utilization of neck dissection for stage I-II supraglottic tumors

Shivee Gilja, Vikram Vasan, Arvind Kumar, Scott A. Roof, Eric M. Genden, Diana N. Kirke

Research output: Contribution to journalArticlepeer-review

Abstract

Background: In 2018, the National Comprehensive Cancer Network treatment guidelines began recommending the use of neck dissection during surgical management of stage I-II supraglottic laryngeal squamous cell carcinoma (LSCC). Methods: Trends and factors associated with the use of neck dissection during larynx-preserving surgery for patients with cT1-2, N0, M0 supraglottic LSCC in the National Cancer Database (2004–2020) were evaluated using multivariable-adjusted logistic regression. Results: Of the 2080 patients who satisfied study eligibility criteria, 633 (30.4%) underwent neck dissection. Between 2018 and 2020, the rate of neck dissection was 39.0% (114/292). After multivariable adjustment, academic facility type, undergoing biopsy prior to surgery, and more radical surgery were significant predictors of receiving neck dissection. Conclusions: The results of this national analysis suggest that the utilization of guideline-concordant neck dissection for management of stage I-II supraglottic LSCC remains low and highlight the need to promote the practice of neck dissection for this patient population.

Original languageEnglish
Pages (from-to)1589-1600
Number of pages12
JournalHead and Neck
Volume46
Issue number7
DOIs
StatePublished - Jul 2024

Keywords

  • elective neck dissection
  • guideline-concordant treatment
  • laryngeal squamous cell carcinoma
  • larynx-preserving surgery
  • supraglottic cancer

Fingerprint

Dive into the research topics of 'Treatment discordance in the utilization of neck dissection for stage I-II supraglottic tumors'. Together they form a unique fingerprint.

Cite this